HAEMATOLOGY

OPEN TO RECRUITMENT — AUSTRALIA

Abbrev. Title

Myeloma 1000

Protocol Title

Myeloma 1000 Project

NEOD001-301 AFFIRM-AL

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

PHI-101-001

A Prospective, Phase la/b, Multicenter Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the FLT3 Inhibitor, PHI-101, Alone in Subjects with Relapsed or Refractory Acute Myeloid Leukaemia (AML)

PXS5505-MF-101

A Phase 1/2a Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients with Primary, Postpolycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

ZN-d5-001

Phase 1 First in Human Dose-Escalation Study of ZN-d5 as a Single Agent in Subjects with Non-Hodgkin Lymphoma or Acute Myeloid Leukaemia